These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 27777100)
1. Corrected Fructosamine improves both correlation with HbA Rodríguez-Segade S; Rodríguez J; Camiña F Clin Biochem; 2017 Feb; 50(3):110-115. PubMed ID: 27777100 [TBL] [Abstract][Full Text] [Related]
2. Fructosamine and glycated hemoglobin in the assessment of glycaemic control in dogs. Loste A; Marca MC Vet Res; 2001; 32(1):55-62. PubMed ID: 11254177 [TBL] [Abstract][Full Text] [Related]
3. Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting. Kengne AP; Erasmus RT; Levitt NS; Matsha TE Prim Care Diabetes; 2017 Apr; 11(2):119-131. PubMed ID: 28132763 [TBL] [Abstract][Full Text] [Related]
4. Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Ko GT; Chan JC; Yeung VT; Chow CC; Tsang LW; Li JK; So WY; Wai HP; Cockram CS Diabetes Care; 1998 Aug; 21(8):1221-5. PubMed ID: 9702423 [TBL] [Abstract][Full Text] [Related]
5. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531 [TBL] [Abstract][Full Text] [Related]
6. HbA1c, Fructosamine, and Glycated Albumin in the Detection of Dysglycaemic Conditions. Ribeiro RT; Macedo MP; Raposo JF Curr Diabetes Rev; 2016; 12(1):14-9. PubMed ID: 26126638 [TBL] [Abstract][Full Text] [Related]
7. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities]. Gołembiewska E Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752 [TBL] [Abstract][Full Text] [Related]
8. [Fructosamine as a parameter for monitoring carbohydrate metabolism in the treatment of diabetes mellitus]. Rotmann D; Husemann C; Schönherr U; Mitzkat HJ Wien Klin Wochenschr Suppl; 1990; 180():69-71; discussion 78-81. PubMed ID: 2321397 [TBL] [Abstract][Full Text] [Related]
9. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study. Rooney MR; Tang O; Pankow JS; Selvin E Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802 [TBL] [Abstract][Full Text] [Related]
10. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C; Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193 [TBL] [Abstract][Full Text] [Related]
12. Various protein and albumin corrections of the serum fructosamine concentration in the diagnosis of canine diabetes mellitus. Jensen AL Vet Res Commun; 1993; 17(1):13-23. PubMed ID: 8367935 [TBL] [Abstract][Full Text] [Related]
13. The Benefit of a Glucose-Sparing PD Therapy on Glycemic Control Measured by Serum Fructosamine in Diabetic Patients in a Randomized, Controlled Trial (IMPENDIA). Li PK; Dorval M; Johnson DW; Rutherford P; Shutov E; Story K; Bargman JM Nephron; 2015; 129(4):233-40. PubMed ID: 25766261 [TBL] [Abstract][Full Text] [Related]
14. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes? Narbonne H; Renacco E; Pradel V; Portugal H; Vialettes B Diabetes Metab; 2001 Nov; 27(5 Pt 1):598-603. PubMed ID: 11694860 [TBL] [Abstract][Full Text] [Related]
15. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes. Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724 [TBL] [Abstract][Full Text] [Related]
16. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672 [TBL] [Abstract][Full Text] [Related]
17. [Correlation of the Levels of Fructosamine and Glycated Hemoglobin with the Blood Glucose Profile in Pregnant Women with Diabetes Mellitus]. Fujimoto CY; da Costa RA; Zaccara Tde A; Paganotti Cde F; Francisco RP Rev Bras Ginecol Obstet; 2016 Jan; 38(1):20-6. PubMed ID: 26814690 [TBL] [Abstract][Full Text] [Related]
18. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment. Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of fasting capillary glucose, fructosamine and glycosylated haemoglobin in detecting diabetes and other glucose tolerance abnormalities compared to oral glucose tolerance test. Herdzik E; Safranow K; Ciechanowski K Acta Diabetol; 2002 Apr; 39(1):15-22. PubMed ID: 12043934 [TBL] [Abstract][Full Text] [Related]